Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Muscle Weakness × telitacicept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 6 Autoimmune Diseases 3 Neuromuscular Diseases 1 Muscle Weakness 1

Interventions

Creatine 2 telitacicept 1 nicotinamide-beta-riboside 1 fludarabine 1 Testosterone 1 Positron-Emission Tomography 1 Magnetic Resonance Imaging 1 Exercise Movement Techniques 1 Eicosapentaenoic Acid 1 Cyclophosphamide 1 Carnitine 1 Autogenic Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

RemeGen Co., Ltd.

Phase 3 Completed

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡